DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 8-K: Current report
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Heller Bridgette P
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Collins Richard Alexander
DexCom | 4: Statement of changes in beneficial ownership of securities-Director AUGUSTINOS NICHOLAS
DexCom | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G
DexCom | 4: Statement of changes in beneficial ownership of securities-Director ALTMAN STEVEN R
DexCom | 10-Q: Q1 2026 Earnings Report
DexCom | 8-K: Dexcom Reports First Quarter 2026 Financial Results
DexCom | SCHEDULE 13G: Others
DexCom | SCHEDULE 13G: Others
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
DexCom | ARS: Annual Report to Security Holders
DexCom | DEFA14A: Others
DexCom | DEF 14A: Definitive information statements
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | SCHEDULE 13G/A: Others